ReGenesys EU (Public limited company)
ReGenesys EU is a Belgian company registered with the Crossroads Bank for Enterprises under enterprise number 0544.577.301. It was founded on 30-12-2013. Its main activity is: Manufacture of basic pharmaceutical products and pharmaceutical preparations. Its annual accounts for 2021 report equity of € -20 027 and a loss of € 10 187. Addrly gives it a financial health grade of E, on a scale from A (safest) to E (most at risk). Its annual accounts for the 2022 financial year have not been filed, although the legal deadline has passed.
Information last updated on 09-10-2026.
Company information
Key figures of ReGenesys EU
| 2021 | |
|---|---|
Profit / lossiWhat the period earned after taxes. A negative amount is a loss. | € -10 187 |
EquityiWhat belongs to the shareholders: capital contributed, reserves and profits kept in the company. | € -20 027 |
Total assetsiEverything the company owns. Equal to total equity and liabilities, which says how it is financed. | € 7 609 |
Gross marginiSales and other operating income, minus purchases of goods and services. What is left to pay the staff and everything else. | - |
Employees (FTE)iAverage number of workers over the period, in full-time equivalents. | - |
Financial estimate
- 1 Shareholders
Similar companies
No other company with the same activity is listed near this one yet.
Frequently asked questions
Is ReGenesys EU still active? Yes. The Crossroads Bank for Enterprises lists ReGenesys EU as active.
What is the VAT number of ReGenesys EU? ReGenesys EU is not registered for VAT. Its enterprise number is 0544.577.301.
When was ReGenesys EU founded? ReGenesys EU was founded on 30-12-2013.
What is the address of ReGenesys EU? The register struck off the registered office of ReGenesys EU (Gaston Geenslaan 1, 3001 Leuven) on 05/01/2026 and records no current seat.
When did ReGenesys EU last file annual accounts? The latest annual accounts of ReGenesys EU were filed on 26-09-2023.
Does ReGenesys EU file its annual accounts on time? The annual accounts of ReGenesys EU for the 2022 financial year have not been filed, although the legal deadline has passed.
Is ReGenesys EU financially healthy? Addrly gives ReGenesys EU a financial health grade of E, on a scale from A (safest) to E (most at risk). The failure probability and the indicators behind it are visible with a free account.
Is ReGenesys EU profitable? The annual accounts of ReGenesys EU for 2021 show a loss of € 10 187.
What is the equity of ReGenesys EU? The equity of ReGenesys EU was € -20 027 at the close of the 2021 financial year.
Who are the directors of ReGenesys EU? The annual accounts of ReGenesys EU record 1 mandate. The name, role and dates are visible with a free account.
Can ReGenesys EU receive Peppol e-invoices? ReGenesys EU is not registered on the Peppol network at the moment.
What does ReGenesys EU do? The main activity of ReGenesys EU is: Manufacture of basic pharmaceutical products and pharmaceutical preparations.